|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910965123103321 |
|
|
Autore |
Chirkov Yuliy Y |
|
|
Titolo |
Beneficial effects of perhexiline in cardiovascular disease states / / Yuliy Y. Chirkov, Aaron L. Sverdlov and John D. Horowitz |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
New York, : Nova Biomedical/Nova Science Publishers, 2010 |
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Edizione |
[1st ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (53 p.) |
|
|
|
|
|
|
Collana |
|
Cardiology research and clinical developments |
|
|
|
|
|
|
Altri autori (Persone) |
|
SverdlovAaron L |
HorowitzJohn D |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Perhexiline - Therapeutic use |
Angina pectoris - Chemotherapy |
Cardiovascular agents |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references (p. [31]-38) and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Clinical applications of perhexiline -- Pharmacokinetics and toxicity of perhexiline -- Pharmacology of perhexiline -- Conclusion and future perspectives. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
Perhexiline, 2-(2,2-dicyclohexylethyl) piperidine, was originally developed as a prophylactic anti-anginal drug in the late 1960s. This book discusses the benefits of perhexiline in the treatment of cardiovascular disease. |
|
|
|
|
|
|
|